Healthcare -
Biotechnology - NASDAQ - US
$ 0.6625
-2.17 %
$ 51.8 M
Market Cap
4.14
P/E
CTMX - NET INCOME
Net Income CTMX - CytomX Therapeutics, Inc.
-569 K
LAST VALUE
91.75%
2 YEAR CAGR
63.23%
5 YEAR CAGR
27.97%
10 YEAR CAGR